Barclays’s MEDIVATION, INC. MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-198,801
Closed -$12M 7123
2016
Q2
$12M Buy
198,801
+99,282
+100% +$5.63M 0.02% 745
2016
Q1
$4.48M Buy
99,519
+31,056
+45% +$1.13M 0.01% 1264
2015
Q4
$3.29M Sell
68,463
-120,435
-64% -$5.2M ﹤0.01% 1625
2015
Q3
$7.93M Buy
188,898
+100,622
+114% +$4.98M 0.01% 1069
2015
Q2
$5.03M Buy
88,276
+57,050
+183% +$3.52M 0.01% 1478
2015
Q1
$2.02M Sell
31,226
-74,214
-70% -$4.25M ﹤0.01% 2311
2014
Q4
$5.22M Sell
105,440
-46,840
-31% -$2.44M 0.01% 1671
2014
Q3
$7.46M Sell
152,280
-26,814
-15% -$1.14M 0.01% 1423
2014
Q2
$6.89M Sell
179,094
-76,140
-30% -$2.57M 0.01% 1454
2014
Q1
$8.17M Buy
255,234
+164,398
+181% +$6.06M 0.01% 1303
2013
Q4
$2.86M Buy
90,836
+39,868
+78% +$1.2M ﹤0.01% 2316
2013
Q3
$1.5M Sell
50,968
-21,350
-30% -$610K ﹤0.01% 2904
2013
Q2
$1.78M Buy
+72,318
New +$1.82M ﹤0.01% 2672

Other funds holding MDVN

Barclays's MDVN Position: Q3 2016 in Review

Barclays sold out of MEDIVATION, INC. (MDVN) in Q3 2016, closing a stake of 198,801 shares — an estimated $12M sold.

Barclays first reported a position in MDVN in Q2 2013 and held it in 13 quarters. The position peaked at $12M in Q2 2016. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

  • Barclays reported no remaining MEDIVATION, INC. position as of Q3 2016 after selling out during the quarter.
  • Barclays sold 198,801 MEDIVATION, INC. shares in Q3 2016, an estimated $12M.
  • Barclays first reported a position in MEDIVATION, INC. in Q2 2013 and held it in 13 quarters.
  • Barclays's MEDIVATION, INC. position peaked at $12M in Q2 2016.
  • 53 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q3 2016.

Based on Barclays's 13F filing for Q3 2016, filed 14 Nov 2016.